| 加科思-B |
LAV Biosciences Fund IV, L.P. |
增持 |
47670875 |
4767.09万股 |
0.06% |
好仓 |
2020-12-21 |
| 花样年控股 |
TCL Technology Group Corporation (formerly known as TCL Corporation) |
减持 |
-144255574 |
101274.00万股 |
0.18% |
好仓 |
2020-12-21 |
| 加科思-B |
施毅 |
增持 |
59587425 |
5958.74万股 |
0.08% |
好仓 |
2020-12-21 |
| 加科思-B |
LAV Coda Limited |
增持 |
42134075 |
4213.41万股 |
0.06% |
好仓 |
2020-12-21 |
| 加科思-B |
LAV Biosciences Fund IV, L.P. |
增持 |
47670875 |
4767.09万股 |
0.06% |
好仓 |
2020-12-21 |
| 加科思-B |
LAV GP IV, L.P. |
增持 |
47670875 |
4767.09万股 |
0.06% |
好仓 |
2020-12-21 |
| 加科思-B |
LAV Corporate IV GP, Ltd. |
增持 |
47670875 |
4767.09万股 |
0.06% |
好仓 |
2020-12-21 |
| 福莱特玻璃 |
JPMorgan Chase & Co. |
减持 |
-9497744 |
4119.92万股 |
0.09% |
好仓 |
2020-12-21 |
| 加科思-B |
Qiming Venture Partners VI, L.P. |
增持 |
48305740 |
4830.57万股 |
0.06% |
好仓 |
2020-12-21 |
| 加科思-B |
Qiming GP VI, L.P. |
增持 |
48305740 |
4830.57万股 |
0.06% |
好仓 |
2020-12-21 |
| 加科思-B |
Qiming Corporate GP VI, Ltd |
增持 |
49605555 |
4960.56万股 |
0.07% |
好仓 |
2020-12-21 |
| 加科思-B |
邝子平 |
增持 |
81825555 |
8182.56万股 |
0.11% |
好仓 |
2020-12-21 |
| 加科思-B |
Rieschel Gary Edward |
增持 |
81825555 |
8182.56万股 |
0.11% |
好仓 |
2020-12-21 |
| 加科思-B |
梁頴宇 |
增持 |
81825555 |
8182.56万股 |
0.11% |
好仓 |
2020-12-21 |
| 春立医疗 |
Morgan Stanley |
减持 |
-2842093 |
291.41万股 |
0.03% |
好仓 |
2020-12-21 |
| 加科思-B |
Center Laboratories Inc. |
增持 |
118818890 |
11881.89万股 |
0.16% |
好仓 |
2020-12-21 |
| 加科思-B |
BioEngine Capital Holding Limited |
增持 |
98330000 |
9833.00万股 |
0.13% |
好仓 |
2020-12-21 |
| 位元堂 |
WANG ON GROUP LIMITED |
增持 |
16000000 |
75732.29万股 |
0.61% |
好仓 |
2020-12-21 |
| 加科思-B |
BioEngine Capital Inc. |
增持 |
98330000 |
9833.00万股 |
0.13% |
好仓 |
2020-12-21 |
| 加科思-B |
HH SPR-III Holdings Limited |
增持 |
56861110 |
5686.11万股 |
0.07% |
好仓 |
2020-12-21 |
